Intense chemotherapy wards off recurrence in half of mantle cell lymphoma patients

More than half of younger mantle cell lymphoma patients who received an intensive regimen of chemotherapy as frontline treatment remain in remission seven years later, researchers at The University of Texas M. D. Anderson Cancer Centre report at the 50th annual meeting of the American Society of Hematology...

Read the whole article on

More from